Tag: Weltruza
-
Teva’s Weltruza Wins FDA Approval for Monthly Schizophrenia Treatment
Teva’s Weltruza wins FDA approval for monthly schizophrenia treatment. Medincell’s delivery technology reduces administration burden, while olanzapine’s metabolic risks remain.